Merit Medical Systems, Inc. (MMSI)

93.24 +1.59 (+1.73%) USD  |  NASDAQ  |  Jan 08, 16:00
93.24 0.00 (0.00%) After-Hours: 20:00
More

Merit Medical Systems Research and Development Expense (Quarterly): 23.97M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for MMSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. 514.00M
Integra LifeSciences Holdings Corp. 20.42M
Masimo Corp. 30.50M
Insulet Corp. 77.20M
Tandem Diabetes Care, Inc. 47.88M